Vaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the Omicron period

Vaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the Omicron period

There is limited evidence of the effectiveness of the CoronaVac vaccine for children against the Omicron SARS-CoV-2 variant. Here, the authors use data from Brazil for children aged 6–11 years and estimate effectiveness of 40% against infection and 59% against severe disease at least two weeks after...

Full description

Bibliographic Details
Main Authors: Pilar T. V. Florentino, Flávia J. O. Alves, Thiago Cerqueira-Silva, Vinicius de Araújo Oliveira, Juracy B. S. Júnior, Adelson G. Jantsch, Gerson O. Penna, Viviane Boaventura, Guilherme L. Werneck, Laura C. Rodrigues, Neil Pearce, Manoel Barral-Netto, Mauricio L. Barreto, Enny S. Paixão
Format: Article
Language:English
Published: Nature Portfolio 2022-08-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-022-32524-5

Internet

https://doi.org/10.1038/s41467-022-32524-5

Similar Items